Equity Profile

COO

The Cooper Companies, Inc.

Health CareHealth Care Supplies$14.9B

Jun4Thu

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

The Cooper Companies, Inc. (COO) is a global medical device company focused on the design, manufacturing, and marketing of contact lenses and surgical instruments....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and will show how well the company is managing its costs and generating income.

$1.10

Revenue

Revenue growth is essential for assessing the company's market demand and overall health, especially in a competitive industry.

$1.1B

Wall Street expectations, options signals, track record, and call prep available with Pro.

COO Q2-2026 Earnings Preview

Context

Company Snapshot

The Cooper Companies, Inc. (COO) is a global medical device company focused on the design, manufacturing, and marketing of contact lenses and surgical instruments. Operating in the Health Care sector, it plays a crucial role in improving vision care and eye health, which is increasingly important as the global population ages and eye-related issues become more prevalent.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+38.00%

Avg Stock Reaction

-0.40%

Last Quarter Recap

In Q1-2026, Cooper Companies reported an EPS of $1.18, exceeding expectations by 14.79%. However, the stock price fell 2.17% the next day, indicating potential market skepticism despite the earnings beat.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect Cooper Companies to continue its positive earnings trajectory, with a consensus EPS of $1.10 for Q2-2026. The market is closely watching for signs of sustained revenue growth amid competitive pressures.

Bull Case

If Cooper Companies beats EPS expectations and shows strong revenue growth, it could signal robust demand for its products, leading to a positive stock reaction.

Bear Case

Conversely, if the company fails to meet earnings expectations or shows signs of declining revenue, it could raise concerns about its market position and lead to a negative stock reaction.

Key Metrics to Watch

EPS

$1.10

Earnings per share is a key indicator of profitability and will show how well the company is managing its costs and generating income.

Revenue

$1.1B

Revenue growth is essential for assessing the company's market demand and overall health, especially in a competitive industry.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will EPS exceed the consensus estimate of $1.10?

A beat on EPS would reinforce the company's ability to manage costs effectively and could boost investor confidence.

What is the revenue outlook for the upcoming quarters?

Revenue trends are critical for understanding market demand and the company's growth potential in a competitive landscape.

Edge

What the Street Is Missing

Why consensus could be wrong

The market may be underestimating the demand for Cooper's products, as recent trends in eye care suggest a growing market that could drive higher-than-expected revenue.

Supporting Evidence

The company has consistently beaten EPS estimates, indicating strong operational performance.

Options pricing suggests a significant move, indicating that traders expect volatility, which could reflect underlying market sentiment.

The recent decline in stock price following earnings beats may signal market skepticism that could be unwarranted if revenue growth is strong.

Key Risk

If revenue exceeds $1.1B, it could challenge the current bearish sentiment and validate the company's growth narrative.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is pivotal as it will indicate whether the company can maintain its growth trajectory amidst market challenges.

Bull Confirmed If

An EPS of $1.15 or higher, coupled with revenue growth above $1.1B, would confirm a strong bull case.

Bear Confirmed If

An EPS below $1.05 or revenue significantly under $1.0B would support the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±10.43%

Historical Avg

±0.9%

Pricing rich

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.

Options are pricing ±10.4% while COO has averaged ±0.9% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.6%

30d HV

23.8%

Calls (34K)P/C Ratio: 3.83Puts (11K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Cooper Companies beats expectations, history suggests a potential stock increase of around 0.95% on the first trading day post-earnings.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further guidance.

Miss

A miss could lead to a decline in stock price, with historical patterns suggesting a potential drop of around 0.40%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or innovations in the contact lens segment.
2Management's commentary on market demand and competitive landscape.
3Insights into cost management strategies and their impact on margins.
4Guidance on revenue expectations for the next quarter.
5Any commentary on international market performance and growth opportunities.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Jun1

CRDOAMC

Credo Technology Group Holding Ltd

PreviewView

Jun1

HPEAMC

Company Snapshot

The Cooper Companies, Inc. (COO) is a global medical device company focused on the design, manufacturing, and marketing of contact lenses and surgical instruments....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and will show how well the company is managing its costs and generating income.

$1.10

Revenue

Revenue growth is essential for assessing the company's market demand and overall health, especially in a competitive industry.

$1.1B

Wall Street expectations, options signals, track record, and call prep available with Pro.

COO Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+38.00%

Avg Stock Reaction

-0.40%

Last Quarter Recap

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

If Cooper Companies beats EPS expectations and shows strong revenue growth, it could signal robust demand for its products, leading to a positive stock reaction.

Bear Case

Conversely, if the company fails to meet earnings expectations or shows signs of declining revenue, it could raise concerns about its market position and lead to a negative stock reaction.

Key Metrics to Watch

EPS

$1.10

Earnings per share is a key indicator of profitability and will show how well the company is managing its costs and generating income.

Revenue

$1.1B

Revenue growth is essential for assessing the company's market demand and overall health, especially in a competitive industry.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will EPS exceed the consensus estimate of $1.10?

A beat on EPS would reinforce the company's ability to manage costs effectively and could boost investor confidence.

What is the revenue outlook for the upcoming quarters?

Revenue trends are critical for understanding market demand and the company's growth potential in a competitive landscape.

Edge

What the Street Is Missing

Why consensus could be wrong

The market may be underestimating the demand for Cooper's products, as recent trends in eye care suggest a growing market that could drive higher-than-expected revenue.

Supporting Evidence

The company has consistently beaten EPS estimates, indicating strong operational performance.

Options pricing suggests a significant move, indicating that traders expect volatility, which could reflect underlying market sentiment.

The recent decline in stock price following earnings beats may signal market skepticism that could be unwarranted if revenue growth is strong.

Key Risk

If revenue exceeds $1.1B, it could challenge the current bearish sentiment and validate the company's growth narrative.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is pivotal as it will indicate whether the company can maintain its growth trajectory amidst market challenges.

Bull Confirmed If

An EPS of $1.15 or higher, coupled with revenue growth above $1.1B, would confirm a strong bull case.

Bear Confirmed If

An EPS below $1.05 or revenue significantly under $1.0B would support the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±10.43%

Historical Avg

±0.9%

Pricing rich

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.

Options are pricing ±10.4% while COO has averaged ±0.9% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.6%

30d HV

23.8%

Calls (34K)P/C Ratio: 3.83Puts (11K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Cooper Companies beats expectations, history suggests a potential stock increase of around 0.95% on the first trading day post-earnings.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further guidance.

Miss

A miss could lead to a decline in stock price, with historical patterns suggesting a potential drop of around 0.40%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or innovations in the contact lens segment.
2Management's commentary on market demand and competitive landscape.
3Insights into cost management strategies and their impact on margins.
4Guidance on revenue expectations for the next quarter.
5Any commentary on international market performance and growth opportunities.